Immunological features of 22q11 deletion syndrome

Current Opinion in Pediatrics

Volumn 25, Issue 6, 2013, Pages 730-735

  Gennery, Andrew R ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

hypogammaglobulinemia; management guidelines; newborn screening; thymic transplantation

Indexed keywords

DNA FRAGMENT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE;

ANTIBIOTIC PROPHYLAXIS; ANTIBODY RESPONSE; AUTOIMMUNITY; CD4 LYMPHOCYTE COUNT; CHROMOSOME DELETION 22Q11; CLINICAL FEATURE; COMMON VARIABLE IMMUNODEFICIENCY; DISEASE SEVERITY; GENERAL PRACTITIONER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMORAL IMMUNE DEFICIENCY; HYPOCALCEMIA; HYPOPARATHYROIDISM; HYPOTHYROIDISM; IMMUNE STATUS; IMMUNOGLOBULIN DEFICIENCY; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFLUENZA VACCINATION; LYMPHOCYTOPENIA; MOLECULAR INTERACTION; NEWBORN SCREENING; OPPORTUNISTIC INFECTION; PARATHYROID GLAND; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENT INFECTION; RESPIRATORY TRACT INFECTION; RETICULOENDOTHELIAL SYSTEM; REVIEW; SEVERE COMBINED IMMUNODEFICIENCY; STAPHYLOCOCCUS LUGDUNENSIS; THYMUS TRANSPLANTATION; VACCINATION; VIRAL BRONCHIOLITIS;

22Q11 DELETION SYNDROME; ADOLESCENT; ADULT; AGE FACTORS; CENTRAL TOLERANCE; CHILD; CHILD, PRESCHOOL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HEART DEFECTS, CONGENITAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; HYPOPARATHYROIDISM; INFANT; INFANT, NEWBORN; MALE; NEONATAL SCREENING; PRACTICE GUIDELINES AS TOPIC; T-LYMPHOCYTES; THYMUS GLAND;

EID: 84888133302     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0000000000000027     Document Type: Review

References (26)

1. Jyonouchi S, McDonald-McGinn DM, Bale S, et al. CHARGE (coloboma, heart defect, atresia choanae, retarded growth and development, genital hypoplasia, ear anomalies/deafness) syndrome and chromosome 22q11.2 deletion syndrome: a comparison of immunologic and nonimmunologic phenotypic features. Pediatrics 2009; 123:e871-e877.
2. Sanlaville D, Etchevers HC, Gonzales M, et al. Phenotypic spectrum of CHARGE syndrome in fetuses with CHD7 truncating mutations correlates with expression during human development. J Med Genet 2006; 43:211-217.
3. Le Lievre CS, Le Douarin NM. Mesenchymal derivatives of the neural crest: analysis of chimeric quail and chick embryos. J Embryol Exp Morphol 1975;34:125-154.
4. Haynes BF, Heinly CS. Early human T cell development: analysis of the human thymus at the time of initial entry of hematopoietic stem cells into the fetal thymic microenvironment. J Exp Med 1995; 181:1445-1458.
5. Poliani PL, Facchetti F, Ravanini M, et al. Early defects in human T-cell development severely affect distribution and maturation of thymic stromal cells: possible implications for the pathophysiology of Omenn syndrome. Blood 2009; 114:105-108.
6. Ryan AK, Goodship JA, Wilson DI, et al. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet 1997; 34:798-804.
7. Kwan A, Church JA, Cowan MJ, et al. Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2 years. J Allergy Clin Immunol 2013; 132:140-150.
8. Puck JM. Laboratory technology for population-based screening for severe combined immunodeficiency in neonates: the winner is T-cell receptor excision circles. J Allergy Clin Immunol 2012; 129:607-616.
9. Treleaven J, Gennery A, Marsh J, et al. Guidelines on the use of irradiated blood components prepared by the British Committee for Standards in Haematology blood transfusion task force. Br J Haematol 2011; 152:35-51.
10. Janda A, Sedlacek P, Hönig M, et al. Multicenter survey on the outcome of transplantation of hematopoietic cells in patients with the complete form of DiGeorge anomaly. Blood 2010; 116:2229-2236.
11. Knutsen AP, Baker MW, Markert ML. Interpreting low T-cell receptor excision circles in newborns with DiGeorge anomaly: importance of assessing naive T-cell markers. J Allergy Clin Immunol 2011; 128:1375-1376.
12. Heimall J, Keller M, Saltzman R, et al. Diagnosis of 22q11.2 deletion syndrome and artemis deficiency in two children with T-B-NK immunodeficiency. Clin Immunol 2012; 32:1141-1144.
13. Li B, Li J, Devlin BH, Markert ML. Thymic microenvironment reconstitution after postnatal human thymus transplantation. Clin Immunol 2011; 140:244-259.
14. Chinn IK, Milner JD, Scheinberg P, et al. Thymus transplantation restores the repertoires of forkhead box protein 3 (FoxP3)() and FoxP3(-) T cells in complete DiGeorge anomaly. Clin Exp Immunol 2013; 173:140-149.
15. McDonald R, Dodgen A, Goyal S, et al. Impact of 22q11.2 deletion on the postoperative course of children after cardiac surgery. Pediatr Cardiol 2013;34:341-347.
16. Herwadkar A, Gennery AR, Moran AS, et al. Association between hypoparathyroidism and defective T cell immunity in 22q11.2 deletion syndrome. J Clin Pathol 2010; 63:151-155.
17. McLean-Tooke A, Barge D, Spickett GP, Gennery AR. Flow cytometric analysis of TCR Vbrepertoire in patients with 22q11.2 deletion syndrome. Scand J Immunol 2011; 73:577-578.
18. Patel K, Akhter J, Kobrynski L, et al., International DiGeorge Syndrome Immunodeficiency Consortium. Immunoglobulin deficiencies: the B-lymphocyte side of DiGeorge Syndrome. J Pediatr 2012; 161:950-953.
19. BjörkAH,O ́ skarsdó ttir S,AnderssonBA, Friman V.Antibodydeficiency in adults with 22q11.2 deletion syndrome.AmJMedGenetA2012; 158A:1934-1940
20. Jawad AF, Prak EL, Boyer J, et al. A prospective study of influenza vaccination and a comparison of immunologic parameters in children and adults with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). J Clin Immunol 2011; 31:927-935.
21. Hirasaki S, Murakami K, Mizushima T, et al. Successful treatment of sepsis caused by Staphylococcus lugdunensis in an adult with 22q11.2 deletion syndrome. Intern Med 2012; 51:377-380.
22. Pongpruttipan T, Cook JR, Reyes-Mugica M, et al. Pulmonary extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue associated with granulomatous inflammation in a child with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome). J Pediatr 2012; 161:954-958.
23. Itoh S, Ohno T, Kakizaki S, Ichinohasama R. Epstein-Barr virus-positive T-cell lymphoma cells having chromosome 22q11.2 deletion: an autopsy report of DiGeorge syndrome. Hum Pathol 2011; 42:2037-2041.
24. Tison BE, Nicholas SK, Abramson SL, et al. Autoimmunity in a cohort of 130 pediatric patients with partial DiGeorge syndrome. J Allergy Clin Immunol. 2011. 128, 1115-1117.
25. Lima K, Abrahamsen TG,WolffAB, et al. Hypoparathyroidismand autoimmunity in the 22q11.2 deletion syndrome. Eur J Endocrinol 2011; 165:345-352.
26. Bassett AS, McDonald-McGinn DM, Devriendt K, et al., International 22q11.2 Deletion Syndrome Consortium. Practical guidelines for managing patients with 22q11.2 deletion syndrome. J Pediatr 2011; 159:332-339. This important article by an international consortium details optimum multidisciplinary management.